Why the study?
Does a fixed triple combination of amlodipine/indapamide/perindopril improve treatment adherence and outcomes in patients with hypertension?
Does a fixed triple combination of amlodipine/indapamide/perindopril improve treatment adherence and outcomes in patients with hypertension?
Fixed-dose triple combination therapy with amlodipine, indapamide, and perindopril may improve treatment adherence and outcomes in hypertension management.
Answers are grounded in this paper and cite their sources.
May support adherence benefits of fixed triple therapy in hypertension; extends observational data but leaves randomized confirmation open.
The article describes the current situation in hypertension awareness and treatment, the role of treatment adherence and fixed-dose combinations in its improvement. The real world data form recent studies concerning adherence and outcome on the triple combination of amlodipine/indapamide/perindopril are demonstrated.
No takes yet. Share an insight, caveat, or question.
А. О. Конради (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: